These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 21687359)
1. Polymeric ocular hydrogels and ophthalmic inserts for controlled release of timolol maleate. Singh V; Bushetti SS; Raju SA; Ahmad R; Singh M; Ajmal M J Pharm Bioallied Sci; 2011 Apr; 3(2):280-5. PubMed ID: 21687359 [TBL] [Abstract][Full Text] [Related]
2. Stimuli-sensitive hydrogels: a novel ophthalmic drug delivery system. Singh V; Bushetti SS; Appala R; Shareef A; Imam SS; Singh M Indian J Ophthalmol; 2010; 58(6):477-81. PubMed ID: 20952830 [TBL] [Abstract][Full Text] [Related]
3. Chick chorioallantoic membrane model for in ovo evaluation of timolol maleate-brimonidine tartrate ocular inserts. Ravindran VK; Repala S; Subadhra S; Appapurapu AK Drug Deliv; 2014 Jun; 21(4):307-14. PubMed ID: 24134746 [TBL] [Abstract][Full Text] [Related]
4. Formulation and evaluation of stimuli-sensitive hydrogels of timolol maleate and brimonidine tartrate for the treatment of glaucoma. Dubey A; Prabhu P Int J Pharm Investig; 2014 Jul; 4(3):112-8. PubMed ID: 25126524 [TBL] [Abstract][Full Text] [Related]
5. Carbopol/chitosan based pH triggered in situ gelling system for ocular delivery of timolol maleate. Gupta S; Vyas SP Sci Pharm; 2010; 78(4):959-76. PubMed ID: 21179328 [TBL] [Abstract][Full Text] [Related]
6. The Effect of Polymers on Drug Release Kinetics in Nanoemulsion Vijaya Rani KR; Rajan S; Bhupathyraaj M; Priya RK; Halligudi N; Al-Ghazali MA; Sridhar SB; Shareef J; Thomas S; Desai SM; Pol PD Polymers (Basel); 2022 Jan; 14(3):. PubMed ID: 35160417 [TBL] [Abstract][Full Text] [Related]
7. In situ formation of injectable chitosan-gelatin hydrogels through double crosslinking for sustained intraocular drug delivery. Song Y; Nagai N; Saijo S; Kaji H; Nishizawa M; Abe T Mater Sci Eng C Mater Biol Appl; 2018 Jul; 88():1-12. PubMed ID: 29636124 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and characterization of timolol maleate-loaded quaternized chitosan-based thermosensitive hydrogel: A transparent topical ocular delivery system for the treatment of glaucoma. Pakzad Y; Fathi M; Omidi Y; Mozafari M; Zamanian A Int J Biol Macromol; 2020 Sep; 159():117-128. PubMed ID: 32380105 [TBL] [Abstract][Full Text] [Related]
9. Chitosan-Gelatin Hydrogel Crosslinked With Oxidized Sucrose for the Ocular Delivery of Timolol Maleate. El-Feky GS; Zayed GM; Elshaier YAMM; Alsharif FM J Pharm Sci; 2018 Dec; 107(12):3098-3104. PubMed ID: 30165067 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic differences between ocular inserts and eyedrops. Friedrich SW; Saville BA; Cheng YL; Rootman DS J Ocul Pharmacol Ther; 1996; 12(1):5-18. PubMed ID: 8925396 [TBL] [Abstract][Full Text] [Related]
11. Ophthalmic delivery of hydrophilic drugs through drug-loaded oleogels. Macoon R; Chauhan A Eur J Pharm Sci; 2021 Mar; 158():105634. PubMed ID: 33144182 [TBL] [Abstract][Full Text] [Related]
12. Development and evaluation of polycaprolactone-based electrospun nanofibers containing timolol maleate as a sustained-release device for treatment of glaucoma: Mirzaeei S; Faryadras FB; Mehrandish S; Rezaei L; Daneshgar F; Karami A Res Pharm Sci; 2022 Oct; 17(5):468-481. PubMed ID: 36386485 [TBL] [Abstract][Full Text] [Related]
14. The role of hyaluronan as a drug carrier to enhance the bioavailability of extended release ophthalmic formulations. Hyaluronan-timolol ionic complexes as a model case. Battistini FD; Tártara LI; Boiero C; Guzmán ML; Luciani-Giaccobbe LC; Palma SD; Allemandi DA; Manzo RH; Olivera ME Eur J Pharm Sci; 2017 Jul; 105():188-194. PubMed ID: 28506871 [TBL] [Abstract][Full Text] [Related]
15. Interpenetrating polymeric network (IPNs) in ophthalmic drug delivery: Breaking the barriers. Rathod S Int Ophthalmol; 2023 Mar; 43(3):1063-1074. PubMed ID: 36053474 [TBL] [Abstract][Full Text] [Related]
16. Nanogel-based natural polymers as smart carriers for the controlled delivery of Timolol Maleate through the cornea for glaucoma. Ilka R; Mohseni M; Kianirad M; Naseripour M; Ashtari K; Mehravi B Int J Biol Macromol; 2018 Apr; 109():955-962. PubMed ID: 29154878 [TBL] [Abstract][Full Text] [Related]
17. Preparation and evaluation of a timolol maleate drug-resin ophthalmic suspension as a sustained-release formulation in vitro and in vivo. Qin F; Zeng L; Zhu Y; Cao J; Wang X; Liu W Drug Dev Ind Pharm; 2016; 42(4):535-45. PubMed ID: 26368660 [TBL] [Abstract][Full Text] [Related]
18. Timolol maleate release from hyaluronic acid-containing model silicone hydrogel contact lens materials. Korogiannaki M; Guidi G; Jones L; Sheardown H J Biomater Appl; 2015 Sep; 30(3):361-76. PubMed ID: 25887216 [TBL] [Abstract][Full Text] [Related]
19. Ocular mini-tablets for controlled release of timolol: evaluation in rabbits. Chetoni P; Mariotti Bianchi L; Giannaccini B; Saettone MF; Conte U; Sangalli ME J Ocul Pharmacol Ther; 1996; 12(3):245-52. PubMed ID: 8875330 [TBL] [Abstract][Full Text] [Related]